Common mouse models of chronic kidney disease are not associated with cachexia

被引:4
|
作者
Lair, Benjamin [1 ]
Lac, Marlene [1 ]
Frassin, Lucas [1 ]
Brunet, Manon [2 ]
Buleon, Marie [2 ]
Feuillet, Guylene [2 ]
Maslo, Claire [1 ]
Marques, Marie [1 ]
Monbrun, Laurent [1 ]
Bourlier, Virginie [1 ]
Montastier, Emilie [1 ]
Viguerie, Nathalie [1 ]
Tavernier, Genevieve [1 ]
Laurens, Claire [1 ]
Moro, Cedric [1 ]
机构
[1] Paul Sabatier Univ, Inst Metab & Cardiovasc Dis, Team MetaDiab, INSERM,UMR1297, Toulouse, France
[2] Paul Sabatier Univ, Inst Metab & Cardiovasc Dis, Team Renal Fibrosis & Chron Kidney Dis, INSERM,UMR1297, Toulouse, France
关键词
MUSCLE; PROTEIN;
D O I
10.1038/s42003-024-06021-y
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The 5/6 nephrectomy and adenine-induced nephropathy mouse models have been extensively used to study Chronic Kidney Disease (CKD)-related cachexia. One common caveat of these CKD models is the cross-sectional nature of comparisons made versus controls. We here performed a comprehensive longitudinal assessment of body composition and energy metabolism in both models. The most striking finding is that weight loss is largely driven by reduced food intake which promotes rapid loss of lean and fat mass. However, in both models, mice catch up weight and lean mass a few days after the surgery or when they are switched back to standard chow diet. Muscle force and mass are fully recovered and no sign of cachexia is observed. Our data demonstrate that the time-course of kidney failure and weight loss are unrelated in these common CKD models. These data highlight the need to reconsider the relative contribution of direct and indirect mechanisms to muscle wasting observed in CKD. Chronic kidney disease (CKD) includes loss of renal function combined with numerous other health complications. An investigation of CKD-associated complication of cachexia in mouse models highlights that the time-course of renal failure and muscle wasting are not causal in these models.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Inflammation triggers FGF23 expression in kidneys of chronic kidney disease mouse models
    Egli-Spichtig, D.
    Silva, P. H. Imenez
    Glaudemans, B.
    Gehring, N.
    Bettoni, C.
    Schoenenberger, D.
    Rajski, M.
    Hoogewijs, D.
    Knauf, F.
    Frey-Wagner, I.
    Rogler, G.
    Foeller, M.
    Lang, F.
    Wenger, R. H.
    Frew, I.
    Wagner, C. A.
    ACTA PHYSIOLOGICA, 2016, 216
  • [42] Pregnancy in chronic kidney disease: need for a common language
    Piccoli, Giorgina B.
    Conijn, Anne
    Attini, Rossella
    Biolcati, Marilisa
    Bossotti, Carlotta
    Consiglio, Valentina
    Deagostini, Maria Chiara
    Todros, Tullia
    JOURNAL OF NEPHROLOGY, 2011, 24 (03) : 282 - 299
  • [43] Chronic kidney disease: Prevention and treatment of common complications
    Snively, CS
    Gutierrez, C
    AMERICAN FAMILY PHYSICIAN, 2004, 70 (10) : 1921 - 1928
  • [44] Most common HLA alleles associated with risk and/or protection in chronic kidney disease of undetermined etiology
    Hernandez-Rivera, Juan Carlos H.
    Salazar-Mendoza, Mariana
    Juana Perez-Lopez, Maria
    Gonzalez-Ramos, Jaime
    Espinoza-Perez, Ramon
    Cesar Martinez-Alvarez, Julio
    Trejo-Villeda, Miguel
    Paniagua-Sierra, Ramon
    GACETA MEDICA DE MEXICO, 2019, 155 (03): : 223 - 227
  • [45] The Importance of Testes Function in Mouse Models of Cachexia
    Hardee, Justin P.
    White, James P.
    Puppa, Melissa J.
    Aartun, Johannes D.
    Narsale, Aditi A.
    Sato, Shu
    Carson, James A.
    FASEB JOURNAL, 2012, 26
  • [46] Factors associated with the absence of pharmacological treatment for common modifiable complications in children with chronic kidney disease
    Xu, Yunwen
    Ng, Derek K.
    Furth, Susan L.
    Warady, Bradley A.
    Mitsnefes, Mark M.
    PEDIATRIC NEPHROLOGY, 2021, 36 (10) : 3181 - 3189
  • [47] Urinary metabolites along with common and rare genetic variations are associated with incident chronic kidney disease
    McMahon, Gearoid M.
    Hwang, Shih-Jen
    Clish, Clary B.
    Tin, Adrienne
    Yang, Qiong
    Larson, Martin G.
    Rhee, Eugene P.
    Li, Man
    Levy, Daniel
    O'Donnell, Christopher J.
    Coresh, Josef
    Young, J. Hunter
    Gerszten, Robert E.
    Fox, Caroline S.
    KIDNEY INTERNATIONAL, 2017, 91 (06) : 1426 - 1435
  • [48] Factors associated with the absence of pharmacological treatment for common modifiable complications in children with chronic kidney disease
    Yunwen Xu
    Derek K Ng
    Susan L Furth
    Bradley A Warady
    Mark M Mitsnefes
    Pediatric Nephrology, 2021, 36 : 3181 - 3189
  • [49] Atherosclerotic Vascular Disease Associated with Chronic Kidney Disease
    Tunbridge, Matthew J.
    Jardine, Alan G.
    CARDIOLOGY CLINICS, 2021, 39 (03) : 403 - 414
  • [50] Mouse models of chronic wasting disease: A review
    Cook, Makayla
    Hensley-McBain, Tiffany
    Grindeland, Andrea
    FRONTIERS IN VIROLOGY, 2023, 3